- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06298214
Testing the Effectiveness of the Her Health Program to Add Healthcare Value in the Fourth Trimester (Her Health)
The goal of this clinical trial is to learn if a program Woman's Hospital has made, called the Her Health Program, can help women be healthy and get healthcare in the first year after having a baby.
The main question[s] the study aims to answer are:
- Can the Her Health program increase access to healthcare in the first year postpartum?
- Can the Her Health program increase knowledge about healthcare and change feelings toward the healthcare system?
Participants will complete one research visit in which they will be enrolled and told which group they will be in- "Her Health Program" group or "Usual Care" group. If they are placed in the "Her Health Program" group, they will receive their usual care + the addition of an extra healthcare team member(called a community health navigator) to to work with patients and care team for a year postpartum.
Researchers will compare those who receive the Her Health Program and those who do not receive the program to see if the Her Health Program can help women get healthcare in the first year after having a baby.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70817
- Woman's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- At least 16 years old at the time of consent.
- Gave birth within 7 days before randomization
- Medicaid enrolled
- Address of residence within a disadvantaged area (ADI>5).
- Clearly understands the study procedures and visit schedule, alternative treatments, and risks involved with the study, and voluntarily agrees to participate by giving verbal and written informed consent
Exclusion Criteria:
- Use of private health insurance exclusively
- Does not speak English.
- Plans to move out of state during the study time period
- Unwilling to provide permission to link study records, medical records, and Medicaid and Vital Records Database records.
- Unwilling to provide informed consent
- Unwilling to be randomized.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual Care
Subjects will see doctors as normal during first year postpartum with no assistance.
|
|
|
Experimental: Her Health Program
Her Health is a patient navigation intervention delivered by community health workers across the first postpartum year.
Her Health has two interspersed components: Navigation and Education.
Her Health Navigation is delivered through weekly and monthly check-ins between participant and navigator.
Her Health navigators will deliver historically informed and culturally competent education designed to promote self-efficacy and self-advocacy within the healthcare system.
|
Addition of a community health worker navigator to assist subject in navigating their health in the first year postpartum.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postpartum visit attendance
Time Frame: 12 weeks postpartum
|
Visit attended between 6-12 weeks of delivery (yes/no)
|
12 weeks postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Medical trust
Time Frame: 12 months postpartum
|
Group-Based Medical Mistrust Scale; scores range from 12-60 with higher scores indicating more mistrust
|
12 months postpartum
|
|
Health literacy
Time Frame: 12 months postpartum
|
Rapid Estimate of Adult Literacy in Medicine (REALM); scores 0-66; higher score indicates high literacy
|
12 months postpartum
|
|
Self-efficacy
Time Frame: 12 months postpartum
|
PROMIS General Self-Efficacy; scores range 5-50; higher score indicates higher self-efficacy
|
12 months postpartum
|
|
Healthcare costs
Time Frame: 12 months postpartum
|
total cost of healthcare from Medicaid Claims Database within the first 12 months after delivery
|
12 months postpartum
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Elizabeth Sutton, PhD, Woman's Hospital, Louisiana
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- RP-23-019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Related
-
The University of Texas Health Science Center at...The University of Texas at San AntonioCompleted
-
Gynuity Health ProjectsCuidado Integral de la Mujer, Gineclinic, S.C.; Servicios de Salud Medieg,...Not yet recruitingPregnancy Related | Pregnancy Early
-
4YouandMeCambridge Cognition Ltd; Sema4; Evidation Health; Vector Institute of Artificial... and other collaboratorsCompletedPregnancy Related | Wearables | Pregnancy EarlyUnited States
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
The University of Texas Health Science Center,...CompletedPregnancy Related | Pregnancy, High RiskUnited States
-
Shaare Zedek Medical CenterUnknownPregnancy Related | Pregnancy, High Risk | Anesthesia
-
Portucalense UniversityAveiro University; Unidade Local de Saúde do Alto Ave, EPERecruiting
-
Oregon Health and Science UniversityNot yet recruitingPregnancy Related
-
Oregon Health and Science UniversityRecruiting
-
Biorithm Pte LtdNot yet recruitingPregnancy Related
Clinical Trials on Her Health Program
-
Washington University School of MedicineUniversity of North Carolina, Chapel Hill; Nigerian Institute of Medical ResearchCompleted
-
CooperSurgical Inc.Completed
-
University of MinnesotaUnilever R&D; Nike; Laureus; University of West EnglandCompleted
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)RecruitingOlder Adults | Limitation, MobilityCanada
-
University of WashingtonNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Ankara UniversityCompletedEducation | Fertility | YouthTurkey
-
University of Alabama at BirminghamOhio State University; American Heart Association; Tuskegee UniversityRecruitingCardiovascular Diseases | Smoking | Hypertension | Obesity | Diabetes | Hyperlipidemia | Kidney Disease | Cardiovascular-kidney-metabolic SyndromeUnited States
-
Chinese PLA General HospitalUnknownAdvanced HER-2 Positive Solid Tumors | Chemotherapy Refactory | HER-2 Antibody Inhibitor Therapy RefactoryChina
-
University of MichiganU.S. Department of EducationCompletedUrinary Bladder, Neurogenic | Neurogenic Bowel | Injuries, Spinal CordUnited States
-
ResMedCompleted